Company Filing History:
Years Active: 2012
Title: The Innovations of James Schwing
Introduction
James Schwing is an accomplished inventor based in Cherry Hill, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosing regimens for non-steroidal anti-inflammatory drugs (NSAIDs). With a total of 2 patents, Schwing's work has the potential to improve patient outcomes in pain management.
Latest Patents
One of Schwing's notable patents is the "Immediate release and sustained release ibuprofen dosing regimen." This invention provides a method of administering NSAIDs, specifically propionic acid derivatives like ibuprofen. The inventive dosage forms are designed to deliver an initial release of the NSAID followed by a second sustained release, preferably in a single dosing step. This innovative approach aims to enhance the effectiveness of pain relief while minimizing side effects.
Career Highlights
Throughout his career, Schwing has worked with prominent companies in the pharmaceutical industry. He has been associated with McNeil-PPC, Inc. and Johnson & Johnson Consumer Inc., where he has contributed to the development of various healthcare products. His expertise in drug formulation and delivery systems has been instrumental in advancing the field.
Collaborations
Some of Schwing's notable coworkers include Der-Yang Lee and Frank J Bunick. Their collaborative efforts have further enriched the research and development processes in which they have been involved.
Conclusion
James Schwing's innovative contributions to the pharmaceutical industry, particularly in the area of ibuprofen dosing regimens, highlight his commitment to improving patient care. His work continues to influence the development of effective pain management solutions.